AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 288 filers reported holding AMEDISYS INC in Q2 2019. The put-call ratio across all filers is 1.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $842,437 | +17.7% | 9,213 | -5.3% | 0.09% | +17.1% |
Q1 2023 | $715,715 | -17.0% | 9,731 | -5.7% | 0.08% | -24.0% |
Q4 2022 | $861,799 | -16.8% | 10,316 | -3.6% | 0.10% | -24.2% |
Q3 2022 | $1,036,000 | -7.3% | 10,701 | +0.7% | 0.13% | -1.5% |
Q2 2022 | $1,117,000 | -35.4% | 10,623 | +5.9% | 0.13% | -30.6% |
Q1 2022 | $1,729,000 | +19.1% | 10,033 | +11.8% | 0.19% | +16.3% |
Q4 2021 | $1,452,000 | +62.6% | 8,971 | +49.7% | 0.17% | +49.5% |
Q3 2021 | $893,000 | -35.6% | 5,991 | +5.8% | 0.11% | -39.3% |
Q2 2021 | $1,387,000 | +14.6% | 5,662 | +23.9% | 0.18% | +5.2% |
Q1 2021 | $1,210,000 | -8.1% | 4,571 | +1.8% | 0.17% | -14.3% |
Q4 2020 | $1,316,000 | +24.6% | 4,488 | +0.5% | 0.20% | +9.7% |
Q3 2020 | $1,056,000 | +23.1% | 4,467 | +3.4% | 0.18% | +16.4% |
Q2 2020 | $858,000 | +7.8% | 4,321 | -0.3% | 0.16% | -8.1% |
Q1 2020 | $796,000 | +10.9% | 4,336 | +0.9% | 0.17% | +33.1% |
Q4 2019 | $718,000 | +30.5% | 4,299 | +2.5% | 0.13% | +25.0% |
Q3 2019 | $550,000 | +15.3% | 4,195 | +6.7% | 0.10% | -2.8% |
Q2 2019 | $477,000 | – | 3,931 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
RK Capital | 54,900 | $9,459,000 | 1.86% |
Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |